Egypt Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017

Egypt Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017

Summary

“Egypt Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Egypt Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories – Neurostimulation Devices, Neurological Diagnostic Equipment, Interventional Neurology, CSF Management and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories – Neurostimulation Devices, Neurological Diagnostic Equipment, Interventional Neurology, CSF Management and Neurosurgical Products.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within five market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the five market categories.
- Global corporate-level profiles of key companies operating within the Egypt Neurology Devices market.
- Key players covered include Nihon Kohden Corporation, Medtronic, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Terumo Corporation, KARL STORZ GmbH & Co. KG and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Egypt Neurology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 10
2.1 What is This Report About? 10
3 Neurology Devices In Egypt 11
3.1 Neurology Devices, Egypt, Overall Revenue ($m), 2003-2017 11
3.2 Neurology Devices, Egypt, Category Volume (Units), 2003-2017 17
3.3 Neurology Devices, Egypt, Company Share (2009-2010) 22
4 CSF Management In Egypt 24
4.1 CSF Management Overall Revenue (2003-2017) 24
4.2 CSF Management Overall Volume (2003-2017) 28
4.3 CSF Management Average Price (2003-2017) 30
4.4 CSF Management Distribution Share (2009-2010) 31
4.5 CSF Management, Egypt, Company Share (2009-2010) 32
5 Interventional Neurology In Egypt 33
5.1 Interventional Neurology Overall Revenue (2003-2017) 33
5.1.1 Embolic Systems Revenue (2003-2017) 37
5.1.2 Navigational Systems Revenue (2003-2017) 41
5.2 Interventional Neurology Overall Volume (2003-2017) 45
5.2.1 Embolic Systems Volume (2003-2017) 49
5.2.2 Navigational Systems Volume (2003-2017) 52
5.3 Interventional Neurology Average Price (2003-2017) 54
5.4 Interventional Neurology Distribution Share (2009-2010) 55
5.5 Interventional Neurology, Egypt, Company Share (2009-2010) 56
6 Neurological Diagnostic Equipment In Egypt 58
6.1 Neurological Diagnostic Equipment Overall Revenue (2003-2017) 58
6.2 Neurological Diagnostic Equipment Overall Volume (2003-2017) 62
6.3 Neurological Diagnostic Equipment Average Price (2003-2017) 66
6.4 Neurological Diagnostic Equipment Distribution Share (2009-2010) 67
6.5 Neurological Diagnostic Equipment, Egypt, Company Share (2009-2010) 68
7 Neurostimulation Devices In Egypt 69
7.1 Neurostimulation Devices Overall Revenue (2003-2017) 69
7.2 Neurostimulation Devices Overall Volume (2003-2017) 73
7.3 Neurostimulation Devices Average Price (2003-2017) 77
7.4 Neurostimulation Devices Distribution Share (2009-2010) 78
7.5 Neurostimulation Devices, Egypt, Company Share (2009-2010) 79
8 Neurosurgical Products In Egypt 80
8.1 Neurosurgical Products Overall Revenue (2003-2017) 80
8.2 Neurosurgical Products Overall Volume (2003-2017) 84
8.3 Neurosurgical Products Average Price (2003-2017) 88
8.4 Neurosurgical Products Distribution Share (2009-2010) 89
8.5 Neurosurgical Products, Egypt, Company Share (2009-2010) 90
9 Radiosurgery In Egypt 92
9.1 Radiosurgery Overall Revenue (2003-2007) 92
9.2 Radiosurgery Overall Volume (2003-2007) 93
9.3 Radiosurgery Average Price (2003-2007) 94
10 Overview of Key Companies in Egypt Neurology Devices Market 95
10.1 Nihon Kohden Corporation 95
10.1.1 Company Overview 95
10.2 Medtronic, Inc. 95
10.2.1 Company Overview 95
10.3 B. Braun Melsungen AG 96
10.3.1 Company Overview 96
10.4 Boston Scientific Corporation 96
10.4.1 Company Overview 96
10.5 Terumo Corporation 97
10.5.1 Company Overview 97
10.6 KARL STORZ GmbH & Co. KG 97
10.6.1 Company Overview 97
10.7 St. Jude Medical, Inc. 98
10.7.1 Company Overview 98
10.8 DePuy, Inc. 98
10.8.1 Company Overview 98
10.9 Covidien plc 98
10.9.1 Company Overview 98
10.10 Natus Medical Incorporated 99
10.10.1 Company Overview 99
10.11 Integra LifeSciences Holdings Corporation 99
10.11.1 Company Overview 99
10.12 CareFusion Corporation 100
10.12.1 Company Overview 100
10.13 Cyberonics, Inc. 100
10.13.1 Company Overview 100
10.14 ev3 Inc. 101
10.14.1 Company Overview 101
10.15 Sophysa S.A. 101
10.15.1 Company Overview 101
11 Appendix 102
11.1 Global Markets Direct Research Methodology 102
11.2 Definitions of Markets Covered in the Report 103
11.2.1 Neurology Devices 103
11.3 Secondary Research 106
11.4 Primary Research 106
11.5 Models 107
11.6 Forecasts 107
11.7 Expert Panel Validation 107
11.8 Currency Conversion 108
11.9 Contact Us 108
11.10 Disclaimer 108